Literature DB >> 10896773

Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections.

B Paziak-Domańska1, M Chmiela, A Jarosińska, W Rudnicka.   

Abstract

The pathogenicity of chronic gastroduodenal diseases is very often related to Helicobacter pylori infections. Most H. pylori strains carry the cagA gene encoding an immunodominant 120- to 128-kDa protein which is considered a virulence marker. The majority of CagA-positive H. pylori isolates also produce a 95-kDa protein cytotoxin (VacA) causing vacuolation and degradation of mammalian cells. In our previous study we have shown that live H. pylori bacteria and their sonicates inhibit PHA-driven proliferation of human T lymphocytes. The H. pylori CagA and VacA proteins were suspected of a paralyzing effect of H. pylori on T cell proliferation. In this report, by using isogenic H. pylori mutant strains defective in CagA and VacA proteins, we determined that CagA is responsible for the inhibition of PHA-induced proliferation of T cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896773     DOI: 10.1006/cimm.2000.1654

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  21 in total

Review 1.  Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm.

Authors:  Beverly R E A Dixon; Rafat Hossain; Rachna V Patel; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

2.  Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection.

Authors:  Ellen J Beswick; Iryna V Pinchuk; Rachel B Earley; David A Schmitt; Victor E Reyes
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

Review 3.  Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.

Authors:  Magdalena Chmiela; Eliza Miszczyk; Karolina Rudnicka
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Localized suppression of inflammation at sites of Helicobacter pylori colonization.

Authors:  Alison L Every; Garrett Z Ng; Caroline D Skene; Stacey N Harbour; Anna K Walduck; Michael A McGuckin; Philip Sutton
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

5.  Distinct patterns of mucosal apoptosis in H pylori-associated gastric ulcer are associated with altered FasL and perforin cytotoxic pathways.

Authors:  Heitor-S-P Souza; Marcelo-S Neves; Celeste-C-S Elia; Claudio-J-A Tortori; Ilana Dines; Cesonia-A Martinusso; Kalil Madi; Leonardo Andrade; Morgana-T-L Castelo-Branco
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

6.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

Review 7.  Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature.

Authors:  Jay Luther; Maneesh Dave; Peter D R Higgins; John Y Kao
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

8.  The effect of the cag pathogenicity island on binding of Helicobacter pylori to gastric epithelial cells and the subsequent induction of apoptosis.

Authors:  Yutaka Minohara; David K Boyd; Hal K Hawkins; Peter B Ernst; Janak Patel; Sheila E Crowe
Journal:  Helicobacter       Date:  2007-12       Impact factor: 5.753

9.  Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells.

Authors:  Ellen J Beswick; Irina V Pinchuk; Soumita Das; Don W Powell; Victor E Reyes
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

10.  The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis.

Authors:  T Rokkas; J P Gisbert; Y Niv; C O'Morain
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.